Business · 10/04/2006
FDA Withdraws Guidance on Gamma Irradiation of Blood and Blood Components
The Food and Drug Administration (FDA) is withdrawing a guidance document issued on March 15, 2000, related to the gamma irradiation of blood and blood components, and is instead moving forward with a pilot program for licensing.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →